Interventional Imaging Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Offering (CT Scanners, X-Ray Systems, MRI Systems, Ultrasound Imaging Systems, Others), By Application (Cardiology, Neurology, Musculoskeletal, Oncology, Urology, Gastroenterology, Obstetrics, Gynecology, Others), By Region & Competition, 2021-2031F

May 2026 | 192 pages | ID: I21D386D7B4AEN
TechSci Research

Abstracts

The Global Interventional Imaging Market is projected to grow from USD 26.01 Billion in 2025 to USD 35.74 Billion by 2031, at a 5.44% CAGR. This market encompasses medical technologies like X-ray fluoroscopy, CT, and ultrasound, which provide real-time visualization for guiding minimally invasive surgical procedures. The market's growth is primarily fueled by the rising prevalence of chronic conditions such as cardiovascular diseases and cancer, requiring precise intraoperative guidance, and a broader healthcare shift towards minimally invasive interventions that offer shorter hospital stays and quicker patient recovery compared to traditional surgeries.

A significant hurdle to market expansion, however, is the critical shortage of skilled interventional radiologists and technicians essential for operating these complex systems and interpreting data. In 2025, approximately 67% of radiologists reported understaffing in their practices, according to the American College of Radiology. This substantial workforce gap limits healthcare facilities' capacity to handle increasing procedural volumes and constrains the wider adoption of advanced interventional solutions across both developed and emerging markets.

Market Driver

The foremost driver propelling the Global Interventional Imaging Market is the increasing prevalence of chronic and cardiovascular diseases. As the global burden of complex conditions grows, healthcare providers are increasingly relying on image-guided therapies to deliver precise, minimally invasive treatments that enhance patient outcomes. This escalating demand is supported by epidemiological projections, such as the American Cancer Society's forecast of 2,041,910 new cancer cases in the United States in 2025, prompting hospitals to expand interventional capabilities and boost procurement of advanced fluoroscopy and CT systems.

The second critical force stimulating market development is technological innovation, specifically the integration of artificial intelligence and robotic-assisted interventions. Manufacturers are rapidly deploying AI algorithms to automate complex workflows, reduce radiation exposure, and improve real-time image clarity during delicate surgeries. This trend is demonstrated by significant regulatory milestones, including GE HealthCare securing 100 FDA authorizations for AI-enabled medical devices by July 2025. This technological evolution translates into substantial economic activity, with companies like Boston Scientific reporting $16.7 billion in full-year 2024 net sales, highlighting the lucrative nature of interventional medicine.

Market Challenge

The critical shortage of skilled interventional radiologists and technicians acts as a primary restraint on the global interventional imaging market. These advanced systems demand highly specialized personnel to navigate complex intraoperative procedures and accurately interpret real-time data. When healthcare facilities face a deficit of qualified operators, the utility of such capital-intensive equipment is severely compromised. This labor gap compels hospitals to restrict the volume of minimally invasive procedures they can offer, effectively capping operational capacity and discouraging providers from procuring additional imaging systems, thereby dampening market demand.

This workforce scarcity has tangible repercussions on the adoption rates of new interventional technologies. Without a sufficient pipeline of trained professionals, justifying the return on investment for upgrading or expanding imaging departments becomes challenging. For instance, the Royal College of Radiologists reported a 29% workforce shortfall for clinical radiologists in the United Kingdom in 2024. Such significant staffing voids limit medical centers' ability to manage patient throughput, thereby stalling the revenue growth necessary for reinvestment in the market's latest imaging innovations.

Market Trends

A fundamental structural shift in the market is the migration of interventional procedures to Ambulatory Surgical Centers (ASCs), distinct from traditional hospital-based capacity expansion. Payers and healthcare providers are aggressively redirecting peripheral vascular, pain management, and basic interventional radiology cases to these outpatient settings to leverage operational efficiencies and significantly reduced overhead costs. This transition is a financial imperative for large health systems, which are acquiring independent centers to capture high-margin outpatient revenue streams while reserving main hospital facilities for critical care. This accelerating momentum is evident in the strong financial performance of major operators, with Tenet Healthcare's Ambulatory Care segment seeing net operating revenues jump 11.9% to $1.275 billion by October 2025, substantially outperforming traditional hospital operations.

Simultaneously, leading medical centers are prioritizing the adoption of Hybrid Operating Room configurations to manage increasing procedural complexity. These advanced suites merge the sterility of a traditional surgical theater with high-end fixed imaging systems, enabling multidisciplinary teams to perform intricate vascular and structural heart repairs without requiring patient transport, unlike standard catheterization labs. This consolidation of capabilities is essential for treating higher-acuity patients, as it allows for immediate conversion from minimally invasive techniques to open surgery if intraoperative complications arise. Sustained investment in these capital-intensive environments continues to drive sales of specialized interventional hardware, with Siemens Healthineers' Advanced Therapies segment recording comparable revenue growth of 3.8% by November 2025, largely due to demand for sophisticated angiography and surgery-supporting systems for these hybrid settings.

Key Market Players

• Becton, Dickinson and Company
• Canon Inc.
• Esaote SpA
• FUJIFILM Holdings Corporation
• Hologic, Inc.
• Intuitive Surgical, Inc.
• Koninklijke Philips NV
• Medtronic plc
• Siemens Healthineers AG
• Stryker Corporation

Report Scope

In this report, the Global Interventional Imaging Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• Interventional Imaging Market, By Offering
• CT Scanners
• X-Ray Systems
• MRI Systems
• Ultrasound Imaging Systems
• Others
• Interventional Imaging Market, By Application
• Cardiology
• Neurology
• Musculoskeletal
• Oncology
• Urology
• Gastroenterology
• Obstetrics
• Gynecology
• Others
• Interventional Imaging Market, By Region
• North America
• United States
• Canada
• Mexico
• Europe
• France
• United Kingdom
• Italy
• Germany
• Spain
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• South America
• Brazil
• Argentina
• Colombia
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Interventional Imaging Market.

Available Customizations:

Global Interventional Imaging Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Contents

1. PRODUCT OVERVIEW

1.1. Market Definition
1.2. Scope of the Market
  1.2.1. Markets Covered
  1.2.2. Years Considered for Study
  1.2.3. Key Market Segmentations

2. RESEARCH METHODOLOGY

2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations

3. EXECUTIVE SUMMARY

3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends

4. VOICE OF CUSTOMER

5. GLOBAL INTERVENTIONAL IMAGING MARKET OUTLOOK

5.1. Market Size & Forecast
  5.1.1. By Value
5.2. Market Share & Forecast
  5.2.1. By Offering (CT Scanners, X-Ray Systems, MRI Systems, Ultrasound Imaging Systems, Others)
  5.2.2. By Application (Cardiology, Neurology, Musculoskeletal, Oncology, Urology, Gastroenterology, Obstetrics, Gynecology, Others)
  5.2.3. By Region
  5.2.4. By Company (2025)
5.3. Market Map

6. NORTH AMERICA INTERVENTIONAL IMAGING MARKET OUTLOOK

6.1. Market Size & Forecast
  6.1.1. By Value
6.2. Market Share & Forecast
  6.2.1. By Offering
  6.2.2. By Application
  6.2.3. By Country
6.3. North America: Country Analysis
  6.3.1. United States Interventional Imaging Market Outlook
    6.3.1.1. Market Size & Forecast
      6.3.1.1.1. By Value
    6.3.1.2. Market Share & Forecast
      6.3.1.2.1. By Offering
      6.3.1.2.2. By Application
  6.3.2. Canada Interventional Imaging Market Outlook
    6.3.2.1. Market Size & Forecast
      6.3.2.1.1. By Value
    6.3.2.2. Market Share & Forecast
      6.3.2.2.1. By Offering
      6.3.2.2.2. By Application
  6.3.3. Mexico Interventional Imaging Market Outlook
    6.3.3.1. Market Size & Forecast
      6.3.3.1.1. By Value
    6.3.3.2. Market Share & Forecast
      6.3.3.2.1. By Offering
      6.3.3.2.2. By Application

7. EUROPE INTERVENTIONAL IMAGING MARKET OUTLOOK

7.1. Market Size & Forecast
  7.1.1. By Value
7.2. Market Share & Forecast
  7.2.1. By Offering
  7.2.2. By Application
  7.2.3. By Country
7.3. Europe: Country Analysis
  7.3.1. Germany Interventional Imaging Market Outlook
    7.3.1.1. Market Size & Forecast
      7.3.1.1.1. By Value
    7.3.1.2. Market Share & Forecast
      7.3.1.2.1. By Offering
      7.3.1.2.2. By Application
  7.3.2. France Interventional Imaging Market Outlook
    7.3.2.1. Market Size & Forecast
      7.3.2.1.1. By Value
    7.3.2.2. Market Share & Forecast
      7.3.2.2.1. By Offering
      7.3.2.2.2. By Application
  7.3.3. United Kingdom Interventional Imaging Market Outlook
    7.3.3.1. Market Size & Forecast
      7.3.3.1.1. By Value
    7.3.3.2. Market Share & Forecast
      7.3.3.2.1. By Offering
      7.3.3.2.2. By Application
  7.3.4. Italy Interventional Imaging Market Outlook
    7.3.4.1. Market Size & Forecast
      7.3.4.1.1. By Value
    7.3.4.2. Market Share & Forecast
      7.3.4.2.1. By Offering
      7.3.4.2.2. By Application
  7.3.5. Spain Interventional Imaging Market Outlook
    7.3.5.1. Market Size & Forecast
      7.3.5.1.1. By Value
    7.3.5.2. Market Share & Forecast
      7.3.5.2.1. By Offering
      7.3.5.2.2. By Application

8. ASIA PACIFIC INTERVENTIONAL IMAGING MARKET OUTLOOK

8.1. Market Size & Forecast
  8.1.1. By Value
8.2. Market Share & Forecast
  8.2.1. By Offering
  8.2.2. By Application
  8.2.3. By Country
8.3. Asia Pacific: Country Analysis
  8.3.1. China Interventional Imaging Market Outlook
    8.3.1.1. Market Size & Forecast
      8.3.1.1.1. By Value
    8.3.1.2. Market Share & Forecast
      8.3.1.2.1. By Offering
      8.3.1.2.2. By Application
  8.3.2. India Interventional Imaging Market Outlook
    8.3.2.1. Market Size & Forecast
      8.3.2.1.1. By Value
    8.3.2.2. Market Share & Forecast
      8.3.2.2.1. By Offering
      8.3.2.2.2. By Application
  8.3.3. Japan Interventional Imaging Market Outlook
    8.3.3.1. Market Size & Forecast
      8.3.3.1.1. By Value
    8.3.3.2. Market Share & Forecast
      8.3.3.2.1. By Offering
      8.3.3.2.2. By Application
  8.3.4. South Korea Interventional Imaging Market Outlook
    8.3.4.1. Market Size & Forecast
      8.3.4.1.1. By Value
    8.3.4.2. Market Share & Forecast
      8.3.4.2.1. By Offering
      8.3.4.2.2. By Application
  8.3.5. Australia Interventional Imaging Market Outlook
    8.3.5.1. Market Size & Forecast
      8.3.5.1.1. By Value
    8.3.5.2. Market Share & Forecast
      8.3.5.2.1. By Offering
      8.3.5.2.2. By Application

9. MIDDLE EAST & AFRICA INTERVENTIONAL IMAGING MARKET OUTLOOK

9.1. Market Size & Forecast
  9.1.1. By Value
9.2. Market Share & Forecast
  9.2.1. By Offering
  9.2.2. By Application
  9.2.3. By Country
9.3. Middle East & Africa: Country Analysis
  9.3.1. Saudi Arabia Interventional Imaging Market Outlook
    9.3.1.1. Market Size & Forecast
      9.3.1.1.1. By Value
    9.3.1.2. Market Share & Forecast
      9.3.1.2.1. By Offering
      9.3.1.2.2. By Application
  9.3.2. UAE Interventional Imaging Market Outlook
    9.3.2.1. Market Size & Forecast
      9.3.2.1.1. By Value
    9.3.2.2. Market Share & Forecast
      9.3.2.2.1. By Offering
      9.3.2.2.2. By Application
  9.3.3. South Africa Interventional Imaging Market Outlook
    9.3.3.1. Market Size & Forecast
      9.3.3.1.1. By Value
    9.3.3.2. Market Share & Forecast
      9.3.3.2.1. By Offering
      9.3.3.2.2. By Application

10. SOUTH AMERICA INTERVENTIONAL IMAGING MARKET OUTLOOK

10.1. Market Size & Forecast
  10.1.1. By Value
10.2. Market Share & Forecast
  10.2.1. By Offering
  10.2.2. By Application
  10.2.3. By Country
10.3. South America: Country Analysis
  10.3.1. Brazil Interventional Imaging Market Outlook
    10.3.1.1. Market Size & Forecast
      10.3.1.1.1. By Value
    10.3.1.2. Market Share & Forecast
      10.3.1.2.1. By Offering
      10.3.1.2.2. By Application
  10.3.2. Colombia Interventional Imaging Market Outlook
    10.3.2.1. Market Size & Forecast
      10.3.2.1.1. By Value
    10.3.2.2. Market Share & Forecast
      10.3.2.2.1. By Offering
      10.3.2.2.2. By Application
  10.3.3. Argentina Interventional Imaging Market Outlook
    10.3.3.1. Market Size & Forecast
      10.3.3.1.1. By Value
    10.3.3.2. Market Share & Forecast
      10.3.3.2.1. By Offering
      10.3.3.2.2. By Application

11. MARKET DYNAMICS

11.1. Drivers
11.2. Challenges

12. MARKET TRENDS & DEVELOPMENTS

12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments

13. GLOBAL INTERVENTIONAL IMAGING MARKET: SWOT ANALYSIS

14. PORTER'S FIVE FORCES ANALYSIS

14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Products

15. COMPETITIVE LANDSCAPE

15.1. Becton, Dickinson and Company
  15.1.1. Business Overview
  15.1.2. Products & Services
  15.1.3. Recent Developments
  15.1.4. Key Personnel
  15.1.5. SWOT Analysis
15.2. Canon Inc.
15.3. Esaote SpA
15.4. FUJIFILM Holdings Corporation
15.5. Hologic, Inc.
15.6. Intuitive Surgical, Inc.
15.7. Koninklijke Philips NV
15.8. Medtronic plc
15.9. Siemens Healthineers AG
15.10. Stryker Corporation

16. STRATEGIC RECOMMENDATIONS

17. ABOUT US & DISCLAIMER